Background And Objectives: Transplant glomerulopathy (TGP) has been proposed to be a component of chronic antibody-mediated rejection (AMR). We have studied 36 patients with TGP and 51 patients with chronic allograft nephropathy (CAN) but without TGP for C4d staining and donor-specific anti-HLA antibodies (DSA) to investigate the alloantibody-mediated mechanisms.

Design, Setting, Participants, & Measurements: Allograft biopsies were stained with C4d staining and DSAs were studied by Luminex Flow Beads. Allograft biopsies were done at a mean of 5.3 +/- 5.0 and 5.6 +/- 4.6 yr after transplantation in patients with CAN and TGP, respectively.

Results: The mean creatinine level at the time of the biopsy was 2.7 +/- 1.2 mg/dl in each group. Proteinuria of >1.0 g/d was more common in patients with TGP (61 versus 25%; P = 0.002). Whereas three patients with TGP had a history of acute AMR, none of the patients with CAN had. Mean chronicity score of the biopsies were 1.7 +/- 0.7 in patients with CAN and 1.9 +/- 0.8 in patients with TGP. Biopsies from only two (4%) patients with CAN and four (11%) patients with TGP had diffuse C4d positivity. DSA were found in 36% of TGP and 33% of CAN patients.

Conclusions: These results suggest that a substantial number of patients with TGP did not have positive C4d staining or DSA, indicating that a non-alloantibody-mediated process may be involved in the development of TGP in some patients.

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.02420607DOI Listing

Publication Analysis

Top Keywords

patients tgp
28
c4d staining
16
patients
12
tgp
11
transplant glomerulopathy
8
tgp patients
8
allograft biopsies
8
biopsies +/-
8
+/- patients
8
c4d
5

Similar Publications

Objective: This study aimed to investigate the efficacy and safety of a triple therapy consisting of colchicine, thalidomide and total glucosides of paeony (TGP) in Behcet's disease (BD) patients with mucocutaneous involvement.

Methods: Totally 355 newly diagnosed BD patients with mucocutaneous involvement were recruited, who received dexamethasone and colchicine for the first 2 weeks, then they were categorized into "sustained triple-therapy (ST)" (n = 231) and "colchicine to triple-therapy (CT)" (n = 124) groups respectively: for ST group, patients received colchicine, thalidomide plus TGP from Month (M)0.5 to M12; for CT group, patients received colchicine from M0.

View Article and Find Full Text PDF

Purpose/objectives: Tracking patient dose in radiation oncology is challenging due to disparate electronic systems from various vendors. Treatment planning systems (TPS), radiation oncology information systems (ROIS), and electronic health records (EHR) lack uniformity, complicating dose tracking and reporting. To address this, we examined practices in multiple radiation oncology settings and proposed guidelines for current systems.

View Article and Find Full Text PDF
Article Synopsis
  • This study aimed to examine the effects of transcutaneous gastric pacing (TGP) on gastrointestinal motility in patients with early-stage acute pancreatitis (AP).
  • A total of 65 AP patients were divided into two groups, with one receiving conventional treatment and the other receiving TGP, which showed significant improvements in symptoms, recovery of intestinal motility, and reductions in hospital stays.
  • The results suggested that TGP enhances gastric motility by influencing autonomic nervous function and certain gastric hormones, potentially providing a new therapeutic approach for AP patients.
View Article and Find Full Text PDF
Article Synopsis
  • This study investigates the genetic underpinnings of neuroendocrine tumors (NETs) by using targeted gene panels (TGPs) to identify novel genetic variants in a group of 93 patients with different NET subtypes.
  • Out of the identified variants, some were already known to be linked to specific tumor types, while others were new associations that had not been previously recognized in the context of NETs.
  • The research highlights the potential of TGPs to uncover previously unknown genetic factors in NET development, suggesting the need for further studies with larger samples to confirm these findings.
View Article and Find Full Text PDF

: Determining how a patient with metastatic cancer is responding to therapy can be difficult for medical oncologists, especially with text-only radiology reports. In this investigation, we assess the clinical usefulness of a new algorithm-based analysis that provides spatial location and quantification for each detected lesion region of interest (ROI) and compare it to information included in radiology reports in the United States. : Treatment response radiology reports for FDG PET/CT scans were retrospectively gathered from 228 patients with metastatic cancers.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!